Science - January 13 2006.pdf

(18066 KB) Pobierz
untitled
13 January 2006 | $10
444074378.007.png
AMPLIFICATION
CELL BIOLOGY
CLONING
MICROARRAYS
NUCLEIC ACID
ANALYSIS
PROTEIN FUNCTION
& ANALYSIS
QUANTITATIVE
PCR
SOFTWARE
SOLUTIONS
There’s a new kit on the block.
Introducing StrataClone ™ PCR Cloning Kits:
A new, more affordable choice in Topoisomerase I technology
Our StrataClone ™ PCR Cloning Kit * saves you time and money with
• High-performance PCR cloning at a more
affordable price
topoisomerase-based PCR cloning priced lower than the competition.
The simple, three step process, > 95% efficiency guarantee, and
•
Clone both long and short PCR amplicons
with the same kit
affordable pricing make StrataClone ™ PCR Cloning Kits your kit of
choice for topoisomerase-based PCR cloning.
•
High efficiency results in >95% clones
with insert
Need More Information? Give Us A Call:
Stratagene USA and Canada
Order: (800) 424-5444 x3
Technical Services: (800) 894-1304 x2
Ask Us About These Great Products:
Stratagene Europe
Order: 00800-7000-7000
Technical Services: 00800-7400-7400
StrataClone™PCR Cloning Kit
20 reactions 240205
10 reactions 240206
K.K.
Order: 03-5159-2060
Technical Services: 03-5159-2070
a
p
an
StrataClone ™ is a trademarkof Stratagene in the United States.
*Patentpending.
Stratagene
J
444074378.008.png 444074378.009.png 444074378.010.png 444074378.001.png 444074378.002.png
 
GE Healthcare
Greater flexibility and binding
capacity in histidine-tagged
protein purification
Ni Sepharose ™ products from GE Healthcare give you the greatest binding capacity available
for histidine-tagged protein purification. They offer the flexibility to use a variety of formats
and protocols, ensuring the highest possible purity. And with our His GraviTrap ™ and
HisTrap ™ FF crude columns, you can now get pure histidine-tagged proteins directly from
unclarified lysate in just 30 minutes.
Maximum target protein activity is assured with Ni Sepharose, thanks to its tolerance of a
wide range of additives and negligible nickel ion leakage. With up to four times the capacity
of competing products, dramatically increasing your yield while saving on time and
resin/buffer costs is no longer pure imagination.
© 2005 General Electric Company - All rights reserved.
Amersham Biosciences AB, a General Electric company,
going to market as GE Healthcare.
GE18-05
444074378.004.png
CONTENTS
Volume 311, Issue 5758
COVER
Billions of new dollars are pouring into
programs that aim to help poor countries
fight such infectious diseases as AIDS, malaria,
and tuberculosis. But increasing numbers of
people are beginning to ask tough questions
about what the money has accomplished and
what can be done to more quickly translate
cash into care and prevention. See page 162.
Image: Brent Stirton/Getty Images
DEPARTMENTS
139
141
147
150
153
155
173
247
255
EDITORIAL
145
by Donald Kennedy
156
175
Stem Cell Claim Demolished
158
Response R. M. Grant et al.
Continuing Progress in Neuroinformatics
M. S. Gazzaniga et al.
Loss of Grants Hurts the Vulnerable K. Sestak
CORRECTIONS AND CLARIFICATIONS
Diplomacy a Second Chance
159
178
159
160
161
178
161
Scorpions, and Other Many-Legged Creatures
T. Eisner, M. Eisner, M. Siegler,
reviewed by M. Berenbaum
Darwin
162
179
Public-Private Partnerships Proliferate
168
Amount to More Than a Hill of Beans
170
180
C. B. Fisher
172
182
183
184
J. C. Dunlap
>>Report p. 226
186
E. Lellouch
>>Report p. 201
187
J. S. Bader and J. Chant
>>Report p. 239
162
CONTENTS
continued
>>
www.sciencemag.org SCIENCE VOL 311 13 JANUARY 2006
133
444074378.005.png 444074378.006.png
Zgłoś jeśli naruszono regulamin